|
WO2021005599A1
|
|
Heterodimers and methods of use thereof
|
|
AU2019301315A1
|
|
PD1-4-1BBL variant fusion protein and methods of use thereof
|
|
CA3104780A1
|
|
Sirpalpha-4-1bbl variant fusion protein and methods of use thereof
|
|
WO2018127918A1
|
|
A sirp alpha-cd70 fusion protein and methods of use thereof
|
|
KR20190123723A
|
|
PD1-41BBL fusion protein and methods of using the same
|
|
US2019352372A1
|
|
SIRPalpha-41BBL FUSION PROTEIN AND METHODS OF USE THEREOF
|
|
WO2018127916A1
|
|
A pd1-cd70 fusion protein and methods of use thereof
|
|
AU2016227322A1
|
|
Dual signaling protein (DSP) fusion proteins, and methods of using thereof for treating diseases
|
|
IL239671D0
|
|
Stable form of signal converting protein fusion proteins, and methods of use and preparation thereof
|
|
CN105026424A
|
|
Stable form of signal converting protein fusion proteins, and methods of use and preparation thereof
|
|
CN103153332A
|
|
Compositions and methods for treatment of hematological malignancies
|
